Suppliers · Research / RTO · Environmental & marine biotech

Algal Bio

Our principal mission is to cultivate algae's potential based on our unique capabilities built upon our access to approximately 3,000 algae strains. Our unique capabilities with proprietary breeding technology, strain screening capability and cultivation expertise will put us in a unique position unlocking algae's potential for a better future.

active JapanAsia Founded 2018 checked 2026-10-05

Profile

Algal Bio is an active Japanese biotechnology startup founded in 2018 that operates a microalgae biofoundry platform to develop commercial products and solutions for the food, health, and environmental sectors. Headquartered in Kashiwa, Chiba, the company leverages a proprietary library of over 1,260 microalgae strains to provide R&D services and collaborative product development.

Key products include the sleep-enhancing supplement Moneru, launched in 2023, and high-purity astaxanthin produced with Japan Bio Science Laboratory. The company is privately held, backed by investors including UTEC, DBJ Capital, and Kyoto University Innovation Capital. In 2025, it secured a ¥330 million JST A-STEP grant to advance functional ingredients.

Sources#

Industry: Cosmetics, Energy, Food ingredients
Topics: Microalgae (spirulina, chlorella, euglena)
Role: Research / RTO — “…20 years of research at the University of Tokyo. (https://algalbio.co.jp) | <details><summary>Pages read</summ…”

Bio-solutions it supplies 1

D1	Farm nitrate and phosphate runoff controlled by biology — denitrifying bioreactors, wetlands and algal uptake — instead of end-of-pipe chemical dosing

What they offer

Products: Moneru; Serimera; Moneru Tablet (10 days); Moneru Tablet (Standard); Moneru Stick (Mixed Fruit Flavor)

Certifications: Maternity Food Certification

Certifications (website): Maternity Food Certification
Customers & partners: 株式会社アルガルバイオ
Production sites: YOKOHAMA HARDTECH HUB, 12 Nishiki-cho, Naka-ku, Yokohama-shi, Kanagawa, 231-0812 · Taiwan — Chlorella powder
Products (website): Moneru — A supplement supporting quality rest. · Serimera — Unique ingredient used in Algal Bio products. · Moneru Tablet (10 days) — Easily digestible tablet type, delivered in a portable aluminum pouch. · Moneru Tablet (Standard) — Contains higher dosage of Serimera for those wanting more of algae's benefits. · Moneru Stick (Mixed Fruit Flavor) — A convenient stick format for on-the-go consumption. · Moneru — A supplement that supports quality rest, incorporating the unique ingredient Serimera™.
R&D facilities: Kashiwa Venture Plaza

Read from the company's own website: home · about · products · rnd · contact · sustainability

Subsidiaries: イービス藻類産業研究所 (Ebis Algae Industry Research Institute)

News & status 6

2025-03 Latest status: The company acquired the management rights of Abies Algae Industry Research Institute in March 2025. ↗ ↗ ↗
2026-06-24 アルガルバイオ、100種1260株の藻類が生む睡眠･食･素材の革新 - 化粧品業界人必読！週刊粧業オンライン
AlgalBio (アルガルバイオ) is a Tokyo University-origin biotech startup accelerating commercialization with a world-leading library of 100 species and 1,260 strains of algae, plus proprietary breeding and cultivation tech, shifting from contract research to broader …
2025-07-10 東京大学発新興アルガルバイオの藻類、食品原料の素材に　大阪のメーカーが採用 - 日本経済新聞
Algal Bio (アルガルバイオ), a Tokyo University-origin startup, has announced that its microalgae-derived pigment astaxanthin is being adopted as a food ingredient by a Japanese prduct-maker (日本生物科学研究所) for use in health foods and cosmetics. The algae are cultured …
2026-09-02 The Algae Foundry: Algal Bio’s Long Bet on Industry That Doesn’t Exist Yet - Growthstock Pulse
Algal Bio positions itself as an algae biofoundry, owning a 1,260-strain library and handling strain selection, production, and commercialization end-to-end to build an industry around algal bio products rather than just making one product; it emphasizes …
2026-06-30 微細藻類の多様性を事業化海と暮らしを変える東大発バイオの挑戦 | 2026年8月号 | 事業構想オンライン
Algal Bio (アルガルバイオ) is a Tokyo University-origin company founded in 2018 that commercializes microalgae diversity, leveraging two decades of university research. It operates with a growing library (about 100 strains, 1,260+ stocks) and multiple R&D sites, …
2025-07-10 アスタキサンチン高含有の藻類製造、商用化へ — アルガルバイオと日本生物科学研究所の共同開発が結実 | 株式会社アルガルバイオのプレスリリース
Algal Bio is a research-oriented biotech startup focused on microalgae, leveraging its own strain library and cultivation technology to develop domestically produced, high-purity astaxanthin from Hematococcus, with a fully indoor, closed-system production …
2025-08-01 アルガルバイオ、JST A-STEPプログラムに採択。最大3.3億円の支援で、微細藻類由来の機能性原料の実用化を加速 | 株式会社アルガルバイオのプレスリリース
アルガルバイオは、微細藻類由来の機能性原料の開発を進める研究開発型ベンチャーで、JSTのA-STEP実装支援プログラムに採択され、最大3.3億円の支援を2025–2028年の3年間受けます。今後は機能性表示食品としての届け出を目指し、有効性エビデンスや作用機序解明、海外展開の規制調査を進め、藻類原料の早期実用化を加速します。

Network: owners, partners, peers

Ownership & investors 6

investor	The University of Tokyo Edge Capital Partners Co., Ltd
investor	DBJ Capital Co., Ltd
investor	Kyoto University Innovation Capital Co., Ltd
investor	Japan Science and Technology Agency
investor	Abies Ventures, Inc
subsidiary	イービス藻類産業研究所

Partners & deals 1

counterparty

Abies Algae Industry Research Institute (acquired in March 2025)

…The company acquired the management rights of Abies Algae Industry Research Institute in March 2025.…

Similar companies

FEBICO遠東生技 · C.B.N. Alga · Yunnan Boxin Biotech Co.,Ltd · Evergen Resources · Parry Nutraceuticals · Bright Moon Seaweed · CHITOSE Group · ALGAE GLOBAL INNOVATION

Identity & contacts

Contacts, people and legal identity are available to members.